Jerard Segatchian
International Consultancy in Blood Components Quality/Safety Improvement & DDR Strategies AJDIT/Inspection, London, UK
Title: GLOBAL REFLECTIONS ON IMPACT OF NEWER DDR STRATEGIES ON PEDIATRIC TRANSFUSION: Where we were, where are we now, and where are we going!
Biography
Biography: Jerard Segatchian
Abstract
This commentary encompasses, as a preamble, the current views on the laboratory and clinical aspects of pediatric transfusion, cellular therapy and apheresis emergencies, all appearing as theme in TRASCI , appering in April 2018{1}.
In brief, the key areas of this presentation embody: firstly, the newer insights into pediatric apheresis including, hematopoietic progenitor stem cell collection, challenging dynamics of progenitor cell recruitment, individual adaptation of procedural parameters and vigilant evaluation of risk factors/adverse effects: secondly, the essentials in pediatric transfusion with innovative DDR questions in screening, manufacturing processes/procedures, quality assurance, and opportunities for standardization of personalized clinical practices.
IN RESPECT TO WHERE WE WERE AND WHERE ARE NOW:
One of the most important challenges in transfusion practice is to provide factual reflections and evidence-based recommendations on pediatric transfusion, a highly complex area of transfusion science and medicine, covering a broad range of patients from intrauterine life to young adults. In clinical pediatric practice an effective transfusion embodies enormous opportunities & challenges at all levels; for laboratories to be upgraded continuously with validated newer and safer technologies; for suppliers to produce the safest and highly specialized components; for physicians to select applicable components or alternatives while balancing the risks and benefits. A high quality research and development strategies are still needed on which the guidelines should be based.
IN RESPECT TO WHERE WE ARE GOING!
Continual efforts are directed in developing many innovative approaches to this multidisciplinary field by key opinion holders to provide a collective platform for TRASCI readers in line with our future plan (1). This is of particular relevance to current situation as we are witnessing the newer products/processes being introduced to the pediatric fields.